Seneschal Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Seneschal Advisors's BMY Position: Q2 2026 in Review
Seneschal Advisors held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 24 shares worth $1.38K. The position accounts for ﹤0.01% of the portfolio, ranked #223.
Seneschal Advisors first reported a position in BMY in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.46K in Q1 2026. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Seneschal Advisors held 24 shares of Bristol-Myers Squibb worth $1.38K as of Q2 2026.
- Seneschal Advisors left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up ﹤0.01% of Seneschal Advisors's portfolio in Q2 2026, its #223 holding.
- Seneschal Advisors first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 4 quarters since.
- Seneschal Advisors's Bristol-Myers Squibb position peaked at $1.46K in Q1 2026.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Seneschal Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.